Signature Bioscience Raises $43M in Fourth Round of Financing

genomeweb
360dx

Signature Bioscience Raises $43M in Fourth Round of Financing

Jul 09, 2001

NEW YORK, July 9 - Signature Bioscience has completed its fourth round of financing, raising $43 million in a private placement, the company said Monday.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Modified Penetrance of Genetic Coding Variants Affects Disease Risk in Humans
Top Five Articles on GenomeWeb Last Week: Illumina, Tecan, Polygenic Risk Scoring, and More
People in the News: Christopher Bernard, Chris Emery, Jeffery Henderson, Michelle Griffin
In Brief This Week: NanoString, VolitionRx, Grifols, and More
New Products Posted to GenomeWeb: Helomics, Empirical Bioscience, IncellDx, More
Signature Science Wins $2.3M Government Contract to Develop Forensic Tool

The Scan

Not a Unique Challenge Anymore

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Case Goes On

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

The Very Old, Very Young, and Very Talented

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

This Week in PLOS

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Main menu